Schizophrenia Flashcards
Role of pharmacists as part of multidisciplinary teams in mental healthcare (2
D
Detecting, resolving, or preventing drug-related problems.
D
Ensuring safe and efficacious use of medicines.
L
Providing comprehensive drug information to patients and healthcare professionals.
G
Promoting medication adherence.
D
Strategies and advantages of collaborative care
V
Collaborative drug therapy management (CDTM)
D
Case conferencing:
D
agreement between the
pharmacists and physicians reached about the responsibilities taken by the pharmacists
for completing patient assessments, selecting and adjusting drug regimens, and
monitoring patients’ results from pharmacotherapy, among other activities.
M
multidisciplinary meeting of two or more health professionals to
plan care for a specific person with chronic and complex care needs, provides an
opportunity for direct face-to-face dialogue between the referring physician and reviewing pharmacist leading to positive outcomes.
K
Pharmacists’ role in screening and risk assessment in mental illness (2):
K
Public education programs about the core symptoms of depression and how to recognize
them.
K
Mental health first aid for crisis situations.
J
Screening and risk assessment services in community pharmacies for depression:
M
Quality use of medicines:
K
There are many pharmaceutical services that
pharmacists offer in inpatient mental healthcare
K
reviewers of medication charts,
laboratory results, and medication prescribing and educators of patients and other health care
professionals (2).
K
The benefits of medication reviews based on studies
M
Antidepressant treatment adherence is crucial for
M
The most commonly used elements of multifaceted interventions included patient educational strategies,
J
telephone follow-up to
K
educational strategies,
K
monitor patients’ progress, as well as providing medication support and feedback to primary care providers (2).
K
the dose of antipsychotics was computed to be higher than recommended in national treatment guidelines in almost half of the patients and the rate of antipsychotic polypharmacy was also judged to be high (2).
K
Creating a partnership between patients, their families, and their medical providers to assess the patient’s requirements, values, and preferences and tailor care to the patient’s context is known as
K
patient-centered care model
K
associated with better health results, higher patient satisfaction, and greater trust (2).
K
Barriers and facilitators to the implementation of mental health pharmacy services:
K
Organizational culture:
K
Mental health stigma:
K
Pharmacists’ education and training to reduce mental health stigma:
K
Factors affecting pharmacist-physician collaboration:
K
Individual pharmacists’ opinions, values, and attitudes are an important aspect of
K
However, it is found that reconfiguration of the pharmacy is
needed to develop new pharmaceutical-care services, such as
K
